As the 2021 UN Climate Change Conference (COP26) begins in Glasgow this weekend, hedge fund managers remain evenly split over the incorporation of ESG (environmental, social and governance) factors and sustainability metrics into their investment processes, according to a new
Man GLG, the discretionary hedge fund unit of London-headquartered global asset management giant Man Group, now holds the largest number of short positions against UK-listed stocks, followed by Marshall Wace and BlackRock, according to new industry data.
The recent steady flow of new investor capital into hedge funds this year could be showing signs of slowing down, with less than half of managers (44 per cent) seeing positive inflows in September, according to new eVestment research. Overall,
Total hedge fund industry assets have swelled to almost USD4 trillion globally, a rise of nearly USD370 billion since the start of this year, according to new capital flows data.
Massar Capital Management has launched a new discretionary macro hedge fund strategy which aims to capitalise on directional trading opportunities across a broad set of global markets.
Sir Christopher Hohn’s TCI Fund Management has set out a strategic plan to overhaul Canadian National Railway which it says would put the Montreal-headquartered freight railway company “back on track.” The London-based activist hedge fund this week outlined sweeping proposals
Hedge funds’ overall momentum in 2021 has been halted, with managers across a range of strategy classes left counting the cost of September’s bumpy equity and credit market reversal, new industry data published this week shows.
Man Group’s funds under management reached a new high of USD139.5 billion during the third quarter, fueled by positive inflows and strong investment performance, with its hedge fund and alternative strategies driving growth.
Co-founded by former Lynx Asset Management portfolio manager Martin Sandquist, Stockholm-based investment management firm Antiloop brings together discretionary and quantitative trading in a multi-strategy fund that spans commodities, equities, global macro and emerging markets.
The development of molnupiravir, a “potent” oral anti-viral Covid-19 treatment, could help boost flagging consumer stocks reliant on the global economic reopening, as healthcare-focused hedge funds look to rebound following recent losses.
